Danielle Mazza1, Deborah Bateson2, Meredith Frearson3, Philip Goldstone4, Gab Kovacs5, Rod Baber6. 1. Department of General Practice, Monash University, Notting Hill, Victoria, Australia. 2. Family Planning NSW, Ashfield, New South Wales, Australia. 3. Australasian Menopause Society, Melbourne, Victoria, Australia. 4. Marie Stopes International Australia, Melbourne, Victoria, Australia. 5. Department of Obstetrics and Gynaecology, Monash Medical Centre, Clayton, Victoria, Australia. 6. Sydney Medical School, University of Sydney, New South Wales, Australia.
Abstract
BACKGROUND: Australia's abortion rates are among the highest in the developed world. Efficacy of the most commonly used form of contraception (oral contraceptives and condoms) relies on regular user compliance. Long-acting reversible contraception (LARC) virtually eradicates contraceptive failure as it is not user-dependent; however, its uptake has been low. AIM: To provide an overview of barriers to LARC use in Australia and potential strategies to overcome these barriers. METHOD: A roundtable of Australian experts was convened to share clinical perspectives and to explore the barriers and potential strategies to increase LARC use. RESULTS: Three broad barriers to LARC uptake were identified. (i) A paucity of Australian research exists that impedes closure of evidence gaps regarding contraceptive prescription and use. Systematic data collection is required. (ii) Within primary care, lack of familiarity with LARC and misperceptions about its use, lack of access to general practitioners (GPs) trained in LARC insertion/removal and affordability impede LARC uptake. Potential strategies to encourage LARC use include, GP education to promote informed choice by women, training in LARC insertions/removals, effective funding models for nurses to perform LARC insertions/removals, and rapid referral pathways. (iii) At the health system level, primary care incentives to provide LARC to women and health economic analyses to inform government policy changes are required. CONCLUSIONS: Although LARC decreases unintended pregnancies by eliminating user compliance issues, its uptake is low in Australia. Strategies that promote LARC uptake by targeting specific barriers may effectively reduce Australia's high unintended pregnancy rate.
BACKGROUND:Australia's abortion rates are among the highest in the developed world. Efficacy of the most commonly used form of contraception (oral contraceptives and condoms) relies on regular user compliance. Long-acting reversible contraception (LARC) virtually eradicates contraceptive failure as it is not user-dependent; however, its uptake has been low. AIM: To provide an overview of barriers to LARC use in Australia and potential strategies to overcome these barriers. METHOD: A roundtable of Australian experts was convened to share clinical perspectives and to explore the barriers and potential strategies to increase LARC use. RESULTS: Three broad barriers to LARC uptake were identified. (i) A paucity of Australian research exists that impedes closure of evidence gaps regarding contraceptive prescription and use. Systematic data collection is required. (ii) Within primary care, lack of familiarity with LARC and misperceptions about its use, lack of access to general practitioners (GPs) trained in LARC insertion/removal and affordability impede LARC uptake. Potential strategies to encourage LARC use include, GP education to promote informed choice by women, training in LARC insertions/removals, effective funding models for nurses to perform LARC insertions/removals, and rapid referral pathways. (iii) At the health system level, primary care incentives to provide LARC to women and health economic analyses to inform government policy changes are required. CONCLUSIONS: Although LARC decreases unintended pregnancies by eliminating user compliance issues, its uptake is low in Australia. Strategies that promote LARC uptake by targeting specific barriers may effectively reduce Australia's high unintended pregnancy rate.
Authors: Jacqueline Frayne; Yvonne Hauck; Thinh Nguyen; Helena Liira; Vera A Morgan Journal: Scand J Prim Health Care Date: 2021-02-11 Impact factor: 2.581
Authors: Sophie Hickey; Yvette Roe; Caroline Harvey; Sue Kruske; Anton Clifford-Motopi; Ike Fisher; Brenna Bernardino; Sue Kildea Journal: Int J Womens Health Date: 2021-05-18